MRM Health – a clinical-stage biopharmaceutical company, announced that it appointed Katja Conrath, PhD, as Chief Scientific Officer. Dr. Conrath brings more than 15 years of experience in drug discovery and early development in various indications, among which fibrosis and inflammation. She will oversee MRM Health’s non-clinical research and development strategies, as well as the…
Shiru Inc., a sustainable ingredient innovator for the food industry, has appointed Dr. Ranjani Varadan as its first Chief Scientific Officer, with effect from August 1, 2022. Varadan will report directly to Shiru Founder and CEO Dr. Jasmin Hume. Varadan was a key scientist and leader for 10 years at Impossible Foods. She was the…
BD (Becton, Dickinson and Company), a global medical technology company, announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific officer for the company, with immediate effect. He will report to Elizabeth McCombs, executive vice president and chief technology officer for BD. In this role, Smith will be primarily responsible for external innovation…
Tevard Biosciences, a privately-held biotechnology company pioneering tRNA-based gene therapies for rare and severe genetic diseases, announced the appointment of Gopi Shanker, Ph.D., as Chief Scientific Officer and as a member of the company’s executive leadership team. With more than 20 years of experience in industry and academic research, Dr. Shanker will be responsible for…
Synthego, the genome engineering company, announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Other investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego’s total private funding to more than $250 million. Also,…